RX

Recursion Pharmaceuticals IncNASDAQ RXRX Stock Report

Last reporting period 30 Sep, 2024

Updated 20 Nov, 2024

Last price

Market cap $B

1.92

Small

Exchange

XNAS - Nasdaq

View Section: Eyestock Rating

Recursion Fair Value

RX

RXRX stock is not valued by Eyestock.

The last 12 months ended with a loss, and this does not allow us to estimate the value of the company according to eyestock model

Discover Undervalued Companies


Recursion Valuation

Current RXRX share ticker price is 5.75 USD.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Min value

Max value

21.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

Recursion Pharmaceuticals Inc price metrics

-36.43

Annual return (geometric mean)

92.41

Risk (standard deviation) of returns

β

0.82

Beta (volatility compared to market)

It means that RXRX stock is less volatile than the broader market
View Section: Profitability